ANGELA BOWMAN: Open Payments
NPI 1629329032 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 8 payments from 8 companies in 2025. Trend: 2023 $46 · 2024 $1,023 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $116 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| Janssen Pharmaceuticals, Inc | 1 | $99 |
| Eisai Inc. | 1 | $94 |
| COLOPLAST CORP | 1 | $71 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| Dexcom, Inc. | 1 | $35 |
Products named: Wegovy, VOQUEZNA, UZEDY, INVEGA SUSTENNA, Leqembi, Titan, INGREZZA, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
